ENTERA BIO LTD. Increase (Decrease) in Accounts Payable
ENTERA BIO LTD. (ENTX) reported Increase (Decrease) in Accounts Payable of $127.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-07
- ENTERA BIO LTD. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $301.00K, a 20.88% increase year-over-year.
- ENTERA BIO LTD. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$174.00K, a 8800.00% decline year-over-year.
- ENTERA BIO LTD. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $232.00K.
- ENTERA BIO LTD. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$167.00K, a 245.22% decline year-over-year.
- ENTERA BIO LTD. increase (decrease) in accounts payable for fiscal 2025 was $316.00K, a 544.90% increase from fiscal 2024.
- ENTERA BIO LTD. increase (decrease) in accounts payable for fiscal 2024 was $49.00K, a 25.76% decline from fiscal 2023.
- ENTERA BIO LTD. increase (decrease) in accounts payable for fiscal 2023 was $66.00K.
- ENTERA BIO LTD. increase (decrease) in accounts payable for fiscal 2022 was -$149.00K, a 7550.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $127.00K 10-Q · filed 2026-08-07 | $359.00K derived: sum of 3 quarters · filed 2026-08-07 | $192.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$174.00K 10-Q · filed 2026-05-08 | $58.00K derived: sum of 2 quarters · filed 2026-05-08 | -$109.00K derived: sum of 3 quarters · filed 2026-05-08 | $140.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $65.00K derived: sum of 2 quarters · filed 2026-03-27 | $314.00K derived: sum of 3 quarters · filed 2026-08-07 | $316.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | -$167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $82.00K derived: sum of 2 quarters · filed 2026-08-07 | $84.00K 10-Q · filed 2025-11-14 | $32.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $251.00K 10-Q · filed 2026-08-07 | $199.00K derived: sum of 3 quarters · filed 2026-08-07 | $314.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-08 | -$50.00K derived: sum of 2 quarters · filed 2026-05-08 | $65.00K derived: sum of 3 quarters · filed 2026-05-08 | $68.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $63.00K derived: sum of 2 quarters · filed 2026-03-27 | $66.00K derived: sum of 3 quarters · filed 2026-03-27 | $49.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $118.00K derived: sum of 2 quarters · filed 2025-11-14 | $101.00K 10-Q · filed 2025-11-14 | -$380.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$14.00K 10-Q · filed 2025-08-08 | -$495.00K derived: sum of 3 quarters · filed 2025-08-08 | -$171.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$17.00K 10-Q · filed 2025-05-09 | -$498.00K derived: sum of 2 quarters · filed 2025-05-09 | -$174.00K derived: sum of 3 quarters · filed 2025-05-09 | -$84.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$157.00K derived: sum of 2 quarters · filed 2025-03-28 | -$67.00K derived: sum of 3 quarters · filed 2025-03-28 | $66.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $324.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $414.00K derived: sum of 2 quarters · filed 2024-11-08 | $547.00K 10-Q · filed 2024-11-08 | $151.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $223.00K 10-Q · filed 2024-08-09 | -$173.00K derived: sum of 3 quarters · filed 2024-08-09 | $131.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $133.00K 10-Q · filed 2024-05-10 | -$263.00K derived: sum of 2 quarters · filed 2024-05-10 | $41.00K derived: sum of 3 quarters · filed 2024-05-10 | -$49.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$92.00K derived: sum of 2 quarters · filed 2024-03-08 | -$182.00K derived: sum of 3 quarters · filed 2024-03-08 | -$149.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $214.00K derived: sum of 2 quarters · filed 2023-11-14 | $247.00K 10-Q · filed 2023-11-14 | $88.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$57.00K 10-Q · filed 2023-08-11 | -$216.00K derived: sum of 3 quarters · filed 2023-08-11 | -$180.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $33.00K 10-Q · filed 2023-05-05 | -$126.00K derived: sum of 2 quarters · filed 2023-05-05 | -$90.00K derived: sum of 3 quarters · filed 2023-05-05 | -$241.00K derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$123.00K derived: sum of 2 quarters · filed 2023-03-31 | -$274.00K derived: sum of 3 quarters · filed 2023-03-31 | $2.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$115.00K derived: sum of 2 quarters · filed 2022-11-10 | $161.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $125.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $276.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$170.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |